Frequency
of Causes
Peculiar to Secondary Hypertension in A Tertiary
Care Hospital Of
Peshawar
.........................................................................................................................
Dr Hamzullah Khan MBBS
Coauthor: Professor Dr Muhammad Zarif
Professor of Medicine, Khyber Medical College
Peshawar, Pakistan.
Correspondence to:
Dr Hamzullah Khan MBBS
Khyber Medical College
Peshawar, Pakistan
Phone number: 0092-345-9283415
Email: hamzakmc@gmail.com,
Alternative email: hamza_kmc@yahoo.com
|
ABSTRACT
Objectives:
To determine the frequency of causes peculiar
to secondary hypertension in a tertiary
care hospital of Peshawar.
Design:
Prospective observational study.
Sampling:
A total of seventy patients with confirmed
diagnosis of secondary hypertension were
randomly included.
Setting:
Department of Medicine Khyber teaching
hospital Peshawar.
Duration:
From January 2006 to August 2007.
Methods:
Relevant information was recorded from
patients and a treatment chart of the
patients, on a questionnaire designed
in accordance with the objectives of the
study.
Results:
A total of 70 patients with confirmed
diagnosis of secondary hypertension were
randomly included. Of the total, 62.29%
were males and 37.71% females. The age
range of the patients was from 14-78 years
with a mean age of 47.5 years. The causes
of secondary hypertension were: thyrotoxicosis
(34.28%), pregnancy induced hypertension
and pre-eclampsia (27.14%), Cushing syndrome
(17.14%), glomerulonephritis (7.14%),
acromegaly and corticosteroids intake
ocer a long period of time especially
in rheumatoid patients (2.85%), history
of oral contraceptives, NSAIDS intake
over a longe period of time especially
in rheumatoid patients, hypercalcemia,
phaeochromocytoma, polycystic kidney and
renal artery stenosis each recorded in
1.42% of cases.
Conclusion:
Thyrotoxicosis, pregnancy induced
hypertension and pre-eclampsia, Cushing
syndrome and glomerulonephritis, in their
descending order are major contributors
to the development of secondary hypertension
in our patients.
Key
words: Secondary hypertension causes
peculiar to secondary hypertension, Peshawar.
|
While most forms of hypertension
have no known underlying cause (and are thus
known as "essential hypertension"
or "primary hypertension"), in about
10% of the cases, there is a known cause, and
thus the hypertension is secondary hypertension
(or, less commonly, inessential hypertension)1.
Isolated systolic hypertension is the most common
form of hypertension, especially among patients
50 years or older. Worldwide 5% of hypertensive
patients have secondary hypertension. Hyperthyroidism
increases systolic blood pressure by decreasing
systemic vascular resistance, increasing heart
rate, and raising cardiac output. Potential
cardiovascular consequences of hyperthyroidism
include atrial arrhythmias (especially atrial
fibrillation), pulmonary hypertension, left
ventricular hypertrophy, and heart failure.
The prevalence of hypertension is greater among
hyperthyroid patients than euthyroid patients2. Pregnancy-induced hypertension (PIH) is a
form of high blood pressure in pregnancy. It
occurs in about 5 percent to 8 percent of all
pregnancies.
Pregnancy-induced hypertension
is also called toxemia or pre-eclampsia. It
occurs most often in young women with a first
pregnancy. It is more common in twin pregnancies,
in women with chronic hypertension, pre-existing
diabetes, and in women who had PIH in a previous
pregnancy3.
Cardiovascular disease is
the major cause of morbidity and mortality in
Cushing's syndrome and excess risk remains even
in effectively treated patients. The cardiovascular
consequences of cortisol excess are protean
and include, inter alia, elevation of blood
pressure, truncal obesity, hyperinsulinemia,
hyperglycemia, insulin resistance, and dyslipidemia4. Renovascular hypertension (RVHT) denotes
non-essential hypertension in which a causal
relationship exists between anatomically evident
arterial occlusive disease and elevated blood
pressure. RVHT is the clinical consequence of
renin-angiotensin-aldosterone activation as
a result of renal ischemia. Renal artery stenosis
(RAS) is a major cause of RVHT and accounts
for 1-10% of the 50 million cases of hypertension
in the United States5. The present study was
designed as to determine the frequency of causes
peculiar to secondary hypertension in a tertiary
care hospital of Peshawar.
This prospective observational
study was conducted in Department of Medicine
Khyber teaching hospital Peshawar, from January
2006 to August 2007. A total of seventy patients
with confirmed diagnosis of secondary hypertension
were randomly included. Of total 62.29% were
males and 37.71% females.
Relevant information was
recorded from patients and treatment chart of
the patients, on a questionnaire designed in
accordance with the objectives of the study.
Inclusion criteria were all patients who had
established diagnosis of cirrhosis, irrespective
of age and sex, admitted to the Medical department
of Khyber Teaching Hospital (KTH). Exclusion
criteria were all patients with essential or
primary hypertension. Similarly patients with
thyroid diseases or any other renal pathology
that had not yet developed hypertension were
also excluded. Only patients diagnosed by the
consultants as patients suffering from secondary
hypertension in our medical ward were included.
A detailed history of patients
was taken with the help of a pre-designed questionnaire,
prepared in accordance with the objectives of
this study. Family history of hypertension was
also recorded. The questionnaire contained preliminary
information regarding age, sex, address and
education of patients. It also contained information
about causes of secondary hypertension. Blood
pressure of each patient was recorded and hypertension
was defined as systolic blood pressure more
than 140 mm Hg and diastolic blood pressure
more than 95mm Hg on more than one occasion6. Investigation reports of thyroid function
tests, serum cortisole, renal function tests,
radiographs and magnetic resonance angiography
(MRA) for RVT, urine routine examinations and
proteinuria for PIH etc were also recorded from
the ward record of the patients if there were
any. Finally statistical analysis of the data
was performed and association of risk factors
with cirrhosis was studied.
Sampling: A total of 70 patients with confirmed
diagnosis of secondary hypertension were randomly
included. Of the total 62.29% were males and
37.71% females (Table 1).
Age range of patients: The age range of the
patients was from 14-78 years with a mean age
of 47.5 years. The MODE value of age in our
patients was 45 years age (Table 2).
Causes of secondary hypertension: The causes
of secondary hypertension were: thyrotoxicosis
(34.28%), pregnancy induced hypertension and
pre-eclampsia (27.14%), Cushing syndrome (17.14%),
glomerulonephritis (7.14%), acromegaly and corticosteroid
intake for a long period of time especially
in rheumatoid patients at(2.85%), history of
oral contraceptives, NSAID intake for a long
period of time, especially in rheumatoid patients,
hypercalcemia, phaeochromocytoma and Polycystic
kidney and renal artery stenosis each recorded
in 1.42% cases (Table 3).
|
Table 1. Sex wise distribution of patients |
|
Sex of patients |
No of patients |
Percentage of total (%) |
|
Males |
38 |
62.29 |
|
Females |
23 |
37.71 |
|
Table 2. Age wise distribution of patients |
|
Age range |
No of patients |
Percentage of total (%) |
|
14-30 years |
7 |
10.00 |
|
31-60 years |
38 |
54.28 |
|
60-78 years |
25 |
35.71 |
|
Table 3. Causes peculiar to secondary hypertension |
|
Causes peculiar to secondary hypertension |
No of patients |
Percentage of total (%) |
|
Thyrotoxicosis |
24 |
34.28 |
|
Pregnancy induced hypertension and pre-eclampsia |
19 |
27.14 |
|
Cushing syndrome |
12 |
17.14 |
|
Glomerulonephritis |
5 |
7.14 |
|
Acromegaly |
2 |
2.85 |
|
Corticosteroids intake for longer time especially
in rheumatoid patients |
2 |
2.85 |
|
History of oral contraceptives |
1 |
1.42 |
|
NSAIDS intake for longer time especially
in rheumatoid patients |
1 |
1.42 |
|
Hypercalcemia |
1 |
1.42 |
|
Renal artery stenosis |
1 |
1.42 |
|
Phaeochromocytoma |
1 |
1.42 |
|
Polycystic kidney |
1 |
1.42 |
Hypertension is one of the most common worldwide
diseases afflicting humans. Because of the associated
morbidity and mortality and the cost to society,
hypertension is an important public health challenge.
Hypertension is the most important modifiable
risk factor for coronary heart disease (the
leading cause of death in North America), stroke
(the third leading cause), congestive heart
failure, end-stage renal disease, and peripheral
vascular disease7.
The average systolic blood pressure (SBP) of
people aged 30 years or above estimated in 2005
(date from urban population only) reveals as
130-139 mm Hg for Pakistani adults, 120-129
mm Hg for Indians, 140 mm Hg or above for Senegal
and below 120 mm Hg for adults in Thailand8.
Based on recommendations of the Seventh Report
of the Joint National Committee of Prevention,
Detection, Evaluation, and Treatment of High
Blood Pressure (JNC VII), the classification
of blood pressure (expressed in mm Hg) for adults
aged 18 years or older is as follows:
Normal - Systolic lower than 120, diastolic
lower than 80
Pre-hypertension - Systolic 120-139, diastolic
80-99
Stage 1 - Systolic 140-159, diastolic 90-99.
Stage 2 - Systolic equal to or more than 160,
diastolic equal to or more than 1009.
Five percent of adults with hypertension have
the secondary form of hypertension, the cause
and pathophysiologic processes of which are
known. Characteristics that may suggest secondary
hypertension such as abdominal diastolic bruits
(renovascular hypertension), decreased femoral
pulses (coarctation of the aorta), or bitemporal
hemianopias (Cushing's disease).
A combination of a good history and physical
examination, astute observation, and accurate
interpretation of available data usually are
helpful in the diagnosis of a specific causation10.
In the present study 34.28% of cases of secondary
hypertension were attributed to hyperthyroidism.
Similar findings are reported from various studies11-12. The second most important cause of secondary
hypertension is pregnancy induced hypertension
and pre-eclampsia (27.14%). It has been reported
from our country research study that eclampsia
is the second major cause of maternal mortality
in Pakistan and its incidence is 2.31% in our
country 13. Cushing syndrome was encountered
in 17.14% cases of the secondary hypertension.
Hypertension is one of the most distinguishing
features of endogenous Cushing's syndrome, as
it is present in about 80% of adult patients
and in almost half of children and adolescent
patients. Hypertension results from the interplay
of several pathophysiological mechanisms regulating
plasma volume, peripheral vascular resistance
and cardiac output, all of which may be increased.
The therapeutic goal is to find and remove
the cause of excess glucocorticoids, which,
in most cases of endogenous Cushing's syndrome,
is achieved surgically14. Five cases (7.14%)
of the secondary hypertension attributed to
glomerulonephritis. Our findings correlated
with the findings of Arnaud L, et al15. Acromegaly
and corticosteroid intake for a long period
of time, especially in rheumatoid patients,
was recorded in 2.85% patients. Patients with
acromegaly have a significant morbidity and
mortality, associated with cardiovascular disease.
Acromegaly is often complicated by other diseases
such as diabetes mellitus, hypertension, and
coronary artery disease, so the existence of
acromegalic cardiomyopathy remains uncertain16.
From this study we concluded that thyrotoxicosis,
pregnancy induced hypertension and pre-eclampsia,
Cushing syndrome and glomerulonephritis, in
their descending order are major contributors
to the development of secondary hypertension
in our patients. Acromegaly and corticosteroid
intake for a long period of time, especially
in rheumatoid patients, are moderate risk factors,
while history of oral contraceptives, NSAID
intake for a long period of time, especially
in rheumatoid patients, hypercalcemia, phaeochromocytoma,
polycystic kidney and renal artery stenosis
are minor contributors to the development of
secondary hypertension.
- Andreoni KA, Weeks SM, Gerber DA, et al:
Incidence of donor renal fibromuscular dysplasia:
does it justify routine angiography? Transplantation
2002; 73(7): 1112-6.
- Prisant LM, Gujral JS, Mulloy AL.Hyperthyroidism:
a secondary cause of isolated systolic hypertension.J
Clin Hypertens . 2006 ;8(8):596-9.
- Zetter K, Lindeberg SN, Haglund B, Hanson
U. Chronic hypertension as a risk factor for
offspring to be born small for gestational
age. Acta Obstet Gynecol Scand, 2006; 85(9):
1046-50.
- Whitworth JA, Williamson PM, Mangos G, Kelly
JJ.Cardiovascular consequences of cortisol
excess.Vasc Health Risk Manag. 2005; 1(4):291-9.
- Beregi JP, Louvegny S, Gautier C, et al:
Fibromuscular dysplasia of the renal arteries:
comparison of helical CT angiography and arteriography.
AJR Am J Roentgenol 1999; 172(1): 27-34.
- Khan H, Hafizullah, M, Haq IU. Frequency
of risk factors of coronary artery disease
in Peshawar. J Postgrad Med Inst , 2005;19(3):270-75.
- Abergel E, Chatellier G, Battaglia C, Menard
J. Can echocardiography identify mildly hypertensive
patients at high risk, left untreated based
on current guidelines? J Hypertens. Jun 1999;17(6):817-24.
- The Atlas of heart disease and stroke 2004.
Geneva, World Health Organization, WHO/CDC,
2004: 29.
- ALLHAT Collaborative Research Group. Major
cardiovascular events in hypertensive patients
randomized to doxazosin vs chlorthalidone:
the antihypertensive and lipid-lowering treatment
to prevent heart attack trial (ALLHAT). JAMA
2000;283(15):1967-75.
- Akpunonu BE, Mulrow PJ, Hoffman EA. Secondary
hypertension: evaluation and treatment. Dis
Mon 1997 ;43(1):62.
- Evangelisti JT, Thorpe CJ. Thyroid storm--a
nursing crisis. Heart Lung. 1983 Mar;12(2):184-93.
- O'Donovan D, McMahon C, Costigan C, Oslizlok
P, Duff D.Reversible pulmonary hypertension
in neonatal Graves disease. Ir Med J. 1997;
90(4):147-8.
- Jameele RN. Eclampsia: is there a seasonal
variation in incidence? J Obstet Gyneco Res,
1998; 24(2): 121-8.
- Magiakou MA, Smyrnaki P, Chrousos GP. Hypertension
in Cushing's syndrome.
Best Pract Res Clin Endocrinol Metab. 2006
;20(3):467-82.
- Arnaud L, Huart A, Plaisier E, Francois
H, Mougenot B, Tiev K, Kettaneh A, Ronco P,
Rougier JP.ANCA-related crescentic glomerulonephritis
in systemic sclerosis: revisiting the "normotensive
scleroderma renal crisis".
Clin Nephrol. 2007; 68(3):165-70.
- Lombardi G, Colao A, Ferone D, Marzullo
P, Landi ML, Longobardi S, Iervolino E, Cuocolo
A, Fazio S, Merola B, Sacca L.Cardiovascular
aspects in acromegaly: effects of treatment.
Metabolism. 1996; 45:57-60.
|